Aurobindo Pharma Share price target & analyst calls
₹1,571.7-39.20 (-2.43%)
As of 23 Oct 2026
Avg 1-year target
9 of 11 long-term calls BUY₹1,638.134.2% above today's price
Aurobindo Pharma's average 1-year share price target is ₹1,638.13, the average of 8 advisors' latest targets. Targets range from ₹950 to ₹1,955.
Latest: HSBC Securities ₹1,955 · 7 Oct 2026
12
9 BUY · 3 SELL, all horizons
8
with an active 1Y target
39%
37 of 95 closed calls hit
109
all horizons, open and closed
Watch AUROPHARMA for new buy/sell callsGet alertsSee 37 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips · page 2 of 3
SRbySahi ResearchTarget hit
1–2 Weeks* · 28 Aug 2026 · entry ₹1,633.5 · via Sahi Research Telegramexit ₹1,685
KJbyKavita Jain, Arihant Capital MarketsTarget hit
1–2 Weeks* · 4 Aug 2026 · entry ₹1,587.3 · via CNBC Awaaz.exit ₹1,598
KJbyKavita Jain, Arihant Capital MarketsTarget hit
1–2 Weeks* · 4 Aug 2026 · entry ₹1,577 · via CNBC Awaaz.exit ₹1,595
SMbySomil Mehta, SharekhanTarget hit
1–2 Weeks* · 27 Jul 2026 · entry ₹1,551 · via Zee Business (Live)exit ₹1,630
NSbyNagaraj Shetty, HDFC SecuritiesTarget hit
1–2 Weeks* · 23 Jun 2026 · entry ₹1,535 · via NDTV Profit (Live)exit ₹1,610
PPbyPrashant P. SawantTarget hit
1–2 Weeks* · 17 Jun 2026 · entry ₹1,424 · via CNBC Awaaz.exit ₹1,455
RPbyRajesh Palviya, Axis SecuritiesTarget hit
1–2 Weeks* · 7 Apr 2026 · entry ₹1,352.1 · via CNBC Awaaz.exit ₹1,400
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks · 12 Oct 2026 · entry ₹1,711.9 · via CNBC Awaaz.exit ₹1,690
AMbyAjit Mishra, ReligareStop-loss hit
1–2 Weeks · 12 Oct 2026 · entry ₹1,692.5 · via NDTV Profit (Live)exit ₹1,620
MJbyManas JaiswalStop-loss hit
1–2 Weeks* · 12 Oct 2026 · entry ₹1,692.5 · via CNBC Awaaz.exit ₹1,659
RDbyRupak De, LKP SecuritiesStop-loss hit
1–2 Weeks* · 9 Oct 2026 · entry ₹1,687.9 · via Zee Business (Live)exit ₹1,640
RBbyRajesh Bhosale, Angel OneStop-loss hit
1–2 Weeks* · 29 Sept 2026 · entry ₹1,704.2 · via ET Now (Live)exit ₹1,670
RBbyRakesh BansalStop-loss hit
1–2 Weeks* · 21 Sept 2026 · entry ₹1,734.5 · via CNBC Awaaz.exit ₹1,700
KJbyKavita Jain, Arihant Capital MarketsStop-loss hit
1–2 Weeks* · 8 Sept 2026 · entry ₹1,685 · via CNBC Awaaz.exit ₹1,671
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
1–2 Weeks* · 2 Sept 2026 · entry ₹1,643.5 · via CNBC Awaaz.exit ₹1,640
NMbyNooresh MeraniStop-loss hit
1–2 Weeks* · 12 Aug 2026 · entry ₹1,662.4 · via CNBC Awaaz.exit ₹1,625
KSbyKunal SaraogiStop-loss hit
1–2 Weeks* · 10 Aug 2026 · entry ₹1,668 · via Zee Business (Live)exit ₹1,635
RDbyRupak De, LKP SecuritiesStop-loss hit
1–2 Weeks* · 5 Aug 2026 · entry ₹1,587.3 · via Business Todayexit ₹1,570
KSbyKunal SaraogiStop-loss hit
1–2 Weeks · 6 Jul 2026 · entry ₹1,615 · via Zee Business (Live)exit ₹1,590
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 3 Jul 2026 · entry ₹1,610 · via IDBI Capital Research Calls Telegramexit ₹1,583
AAbyAditya Agarwal, Coheron BrokersStop-loss hit
1–2 Weeks* · 9 Jun 2026 · entry ₹1,420 · via Business Todayexit ₹1,395
KPbyKunal Parar, Choice BrokingStop-loss hit
1–2 Weeks* · 1 Apr 2026 · entry ₹1,335.5 · via ET Nowexit ₹1,280
ISbyICICI SecuritiesExpired
1–2 Weeks* · 31 Aug 2026 · entry ₹1,650 · via Economic Times New Stock Recosexit ₹1,679.8
VSbyVikas Sethi, Sethi FinmartTarget hit
Intraday · 1 Oct 2026 · entry ₹1,677.9 · via Zee Business (Live)exit ₹1,690
ISbyICICI SecuritiesTarget hit
Intraday* · 21 Jul 2026 · entry ₹1,549 · via Economic Times Stock Recos Overviewexit ₹1,567.2
AKbyArun Kumar MantriStop-loss hit
Intraday* · 2 Sept 2026 · entry ₹1,682 · via CNBC Awaaz.exit ₹1,669
RSbyRajesh SatputeStop-loss hit
Intraday* · 13 Aug 2026 · entry ₹1,671.6 · via CNBC Awaaz.exit ₹1,660
SSbySandip SabharwalStop-loss hit
Intraday* · 22 Jul 2026 · entry ₹1,564 · via CNBC Awaaz.exit ₹1,560
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+9.5% · 19 calls
- CIPLACipla Ltd.₹1,524+13.9% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+27.3% · 15 calls
- LUPINLupin Limited₹2,576+33.6% · 12 calls
- AUROPHARMA· this stockAurobindo Pharma₹1,638+4.2% · 11 calls
- BIOCONBiocon Ltd₹539+66.7% · 10 calls
Showing 51–100 of 109

